Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

The Effectiveness of Tecar Therapy in Management of Calf Muscle Strain Injuries (MS)

25 april 2026 bijgewerkt door: Nabil Mahmoud Ismail Abdel-Aal, Cairo University
this study will be conducted to investigate the effect of TECAR Therapy on quality of landing, healing and Function in patient with Calf Muscle Strain.

Studie Overzicht

Toestand

Nog niet aan het werven

Conditie

Interventie / Behandeling

Gedetailleerde beschrijving

Calf muscle strain is one of the most common muscle injuries in high-performance athletes and contributes to substantial player downtime because of its high mean time to return to sport and occurrence during critical periods in the competitive season. Published reports on lower-body muscle strain have provided frequent updates on the rehabilitation of high-profile muscle groups, such as the hamstring muscles, and improvements to calf strain management are seldom discussed despite the prevalence of these injuries in competitive sports. In this article, we discuss the diagnosis, treatment, outcomes, risk factors, and prevention of calf muscle strain in athletes.Transfer of Electricity-Capacitive and Resistive (Tecar) therapy is considered a special form of energy that uses frequencies between 300 KHz and 1 MHz and is characterized as a non-invasive high-frequency energy that awakens the body's natural ability to self-regenerate. Thus, it promotes the natural physiological processes of the tissue metabolically, transferring energy without introducing radiation from the external environment. TECAR therapy stands out as a promising yet underexplored modality. Its mechanism of action-utilizing both capacitive and resistive energy transfer-suggests a novel approach to addressing musculoskeletal injuries and pain. While preliminary studies and clinical applications hint at its potential advantages, such as improved tissue healing and pain relief, a comprehensive evaluation of the existing research is necessary to fully understand the role of TECAR therapy in rehabilitation

Studietype

Ingrijpend

Inschrijving (Geschat)

60

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Contact Back-up

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Kind
  • Volwassen

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Aged between 16-39 years of age.
  • not having suffered leg injuries in the past 6 months.
  • not having suffered a triceps sural rupture in the past two years.
  • be diagnosed with latent MTPs in the gastric-soleus complex through manual therapy in the dominant side.
  • Presence of Calf muscles Strain evaluated by Ultrasonography.
  • Athlete willing and able to participate in an exercise program safely.
  • The radiologist also assessed whether the tendon ends could be reduced in passive plantar flexion of the ankle joint with the knee extended.
  • Athlete BMI from 18.5 to 24.9 kg / m2

Exclusion Criteria:

  • connective tissue pathology.
  • lymphatic disorders (lymphadenopathy).
  • Skin injuries (open wounds, infection, psoriasis, tattoos, hematoma).
  • peripheral neuropathies.
  • previous fractures.
  • previous lower limb surgeries (in the past 12 months).

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: TECAR therapy
Thirty patients will receive TECAR therapy combined with conventional treatment three times per week for 12 weeks.
Ander: TECAR therapy
The TECAR intervention was administered to the calf muscle using the Zimmer devicein capacitive (CAP) mode for a duration of 20 min. The therapy was applied with the signal at a variable power with a maximum of 300 W. The frequency used was 500 kHz with an intensity of 40%. The intervention was standardized to a distal-to-proximal stroking rhythm with moderate pressure. For the TECAR intervention, the capacitive (CAP) mode at 500 kHz with 40% intensity and a maximum power of 300 W was chosen to optimize deep tissue heating and promote local blood flow and tissue recovery. The 20 min duration reflects protocols commonly used in therapeutic settings for muscle recovery and rehabilitation plus conventional therapy
Ander: conventional treatment
the patients will receive stretching exercises of the gastrocnemius (straight leg) and soleus (bended knee), eccentric exercises for calf muscles, plus plyometric exercises.
Actieve vergelijker: conventional treatment
Thirty patients will receive conventional treatment three times per week for 12 weeks.
Ander: conventional treatment
the patients will receive stretching exercises of the gastrocnemius (straight leg) and soleus (bended knee), eccentric exercises for calf muscles, plus plyometric exercises.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
size of injury
Tijdsspanne: up to 12 weeks
ultrasonography device will be used to assess size of injury
up to 12 weeks

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
landing error score system
Tijdsspanne: up to 12 weeks
Landing Error Scoring System is a clinical tool used to assess jump-landing mechanics for the video from my jumb land aplication . the feet, ankle, knees, hip, trunk, shoulder, neck and head posture is assessed through the video. it is a 17-item . According to the performance sheet, the questions 1-15 are Yes/No questions that are rated as 0 or 1. The questions 16 are rated as 0, 1, and 2; 0 = soft, 1= average and 2= stiff. the question 17 are rated as 0,1,2; 0= excellent,1 average and 2= poor, so the total score ranges from zero to 19. A higher score indicates poor technique in landing from a jump; a lower score indicates better jump-landing technique. the score are categorized as excellent which less than 4, good score more than four and less than or equal 5, moderate score less than four and poor more than six
up to 12 weeks
jump height
Tijdsspanne: up to 12 weeks
The vertical jump test was performed as a one-legged counter movement jump (CMJ). Starting position was in an upright position with the hands placed behind the back. The subjects quickly bent the knee as much as desired and then immediately jumped upward attempting to maximize the height jumped. The subjects performed three maximal approved trials for each leg, starting with the right and alternating between the right and the left leg. However, if the subject increased hop performance in all three jumps, additional jumps were performed until no increase was seen. The best jump height for each leg was used for data analysis.
up to 12 weeks

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

Cairo University

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

1 mei 2026

Primaire voltooiing (Geschat)

1 december 2026

Studie voltooiing (Geschat)

1 december 2026

Studieregistratiedata

Eerst ingediend

25 april 2026

Eerst ingediend dat voldeed aan de QC-criteria

25 april 2026

Eerst geplaatst (Werkelijk)

1 mei 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

1 mei 2026

Laatste update ingediend die voldeed aan QC-criteria

25 april 2026

Laatst geverifieerd

1 april 2026

Meer informatie

Termen gerelateerd aan deze studie

Trefwoorden

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • P.T.REC/012/006406

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren